Legend Biotech (LEGN) Stock: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$18.64
-0.55 (-2.87%)
▼
5d:
-14.3%
30d:
-9.73%
90d:
-48.62%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LEGN is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LEGN is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.97
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$19.23
3.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $18.64, which is considered oversold relative to its 30-day fair value range of $19.60 to $21.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.1) compared to its historical average (33.2). Remarkably, the market is currently pricing in an annual earnings decline of 14.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a downtrend. The price is currently testing key support at $18.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LEGN scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.25 (+164.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEGN is in a downtrend. The price is currently testing key support at $18.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LEGN scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.25 (+164.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.60 -
$21.63
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 164.2% below Wall St target ($49.25)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.60 -
$21.63
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.61
Resistance Level
$22.05
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.08
Wall Street Target
$49.25
(+164.2%)
Revenue Growth (YoY)
51.9%
Profit Margin
-7.2%
Valuation Discount vs History
-14.0% cheaper
PE vs Historical
21.1 vs 33.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.0%
(market-implied from PE analysis)
1-Year Target
$16.78
(-10%)
2-Year Target
$15.10
(-19%)
3-Year Target
$13.59
(-27%)
3-Yr Target (if PE normalizes)
(PE: 21→33)
$21.40
(+15%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.1 to 33.2
Stabilization Target:
$29.35
(+57.5%)
PE Expansion Potential:
+57.5%
Share & Embed Analysis
Last updated: September 12, 2026 7:19 PM ET
Data refreshes hourly during market hours. Next update: 8:19 PM
Data refreshes hourly during market hours. Next update: 8:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
